Clin2
NCT07452978Possibly a fitNot yet recruiting

Propranolol to prevent PTSD after sexual violence in women

PTSD - Post Traumatic Stress Disorder

Treatments studied

Part of Mental health clinical trials.

This trial tests if a short course of the blood pressure medication propranolol can help prevent post-traumatic stress disorder (PTSD) in women who have recently experienced sexual violence. It may help by interrupting the way fear memories are stored in the brain.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
34 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are a woman (assigned female at birth) and at least 18 years old.
  • You were seen at a Medical-Legal Unit within 72 hours of a sexual assault or rape.
  • You are not currently pregnant or breastfeeding.
  • You are not taking certain heart medications, beta-blockers, or specific drugs for mental health conditions.
  • You do not have asthma, psoriasis, myasthenia gravis, or a personal history of head trauma or neurological issues.
  • You understand and read French, and are willing to use effective birth control.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07187011Not yet recruiting· Phase 2
Testing PT150 for PTSD in veterans

This trial tests a new oral medication, PT150, to see if it helps reduce PTSD symptoms in veterans. You must have had PTSD for at least 3 months and not be taking certain other medications.

San Diego, California
NCT07792122Not yet recruiting· Phase 3
Propranolol for PTSD after violence

This study tests whether propranolol, a medication that may help reduce fear memories, can treat PTSD in women who have experienced violence. Participation involves taking the medication and attending sessions to reactivate traumatic memories.

Montpellier
NCT04985344Recruiting· Phase 3
Propranolol to treat PTSD symptoms in children using memory reactivation

This trial studies whether propranolol (a heart-related medicine) can help children with post-traumatic stress disorder (PTSD) after a special memory-activation session. The goal is to reduce PTSD symptoms compared with the comparison condition.

Toulouse
NCT05853627Recruiting· Phase 4
Propranolol versus standard therapy for trauma imagery reactions

This study tests whether propranolol (a beta-blocker) changed alongside a standard approach can reduce how strongly your body reacts during traumatic imagery. It’s meant for adults who have had a traumatic event and may help lessen fear and stress responses tied to those memories.

Charlestown, Massachusetts
NCT04452500Recruiting· Phase 2
Study drug for PTSD symptoms in Veterans

This trial tests a study medicine that blocks the effects of cortisol (a stress hormone) to reduce PTSD symptoms in Veterans. It’s meant for people with ongoing PTSD symptoms and stable treatments, and it closely checks safety because the medicine can affect sleep, mood, and heart rhythm.

Tuscaloosa, Alabama
NCT07499440Recruiting· Phase 2
Testing a new medicine, HB-1, for PTSD

This trial tests an experimental medicine, HB-1, as a potential treatment for PTSD. It is a 8-week study to see if the medicine is safe and if it reduces PTSD symptoms. You must have a stable medication routine and be willing to take the study pill daily.

Bruce, Australian Capital Territory

Hear when a new PTSD - Post Traumatic Stress Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.